JP2008513467A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513467A5
JP2008513467A5 JP2007532447A JP2007532447A JP2008513467A5 JP 2008513467 A5 JP2008513467 A5 JP 2008513467A5 JP 2007532447 A JP2007532447 A JP 2007532447A JP 2007532447 A JP2007532447 A JP 2007532447A JP 2008513467 A5 JP2008513467 A5 JP 2008513467A5
Authority
JP
Japan
Prior art keywords
composition
weight
amount
bupivacaine
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007532447A
Other languages
English (en)
Japanese (ja)
Other versions
JP5285275B2 (ja
JP2008513467A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/032863 external-priority patent/WO2006033948A2/en
Publication of JP2008513467A publication Critical patent/JP2008513467A/ja
Publication of JP2008513467A5 publication Critical patent/JP2008513467A5/ja
Application granted granted Critical
Publication of JP5285275B2 publication Critical patent/JP5285275B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007532447A 2004-09-17 2005-09-15 制御されたデリバリーシステム Expired - Fee Related JP5285275B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61079704P 2004-09-17 2004-09-17
US60/610,797 2004-09-17
US69139505P 2005-06-17 2005-06-17
US60/691,395 2005-06-17
PCT/US2005/032863 WO2006033948A2 (en) 2004-09-17 2005-09-15 Sustained local anesthetic composition containing preferably a sugar ester such as saib

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008252115A Division JP5285374B2 (ja) 2004-09-17 2008-09-30 制御されたデリバリーシステム

Publications (3)

Publication Number Publication Date
JP2008513467A JP2008513467A (ja) 2008-05-01
JP2008513467A5 true JP2008513467A5 (enExample) 2008-11-06
JP5285275B2 JP5285275B2 (ja) 2013-09-11

Family

ID=35949130

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007532447A Expired - Fee Related JP5285275B2 (ja) 2004-09-17 2005-09-15 制御されたデリバリーシステム
JP2008252115A Expired - Fee Related JP5285374B2 (ja) 2004-09-17 2008-09-30 制御されたデリバリーシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008252115A Expired - Fee Related JP5285374B2 (ja) 2004-09-17 2008-09-30 制御されたデリバリーシステム

Country Status (25)

Country Link
US (9) US8753665B2 (enExample)
EP (4) EP2767292B1 (enExample)
JP (2) JP5285275B2 (enExample)
KR (2) KR101351771B1 (enExample)
AT (1) ATE537844T1 (enExample)
AU (1) AU2005287175B2 (enExample)
BR (1) BRPI0515372B8 (enExample)
CA (1) CA2581287C (enExample)
CY (2) CY1112625T1 (enExample)
DK (3) DK2767292T3 (enExample)
EA (2) EA014852B1 (enExample)
ES (3) ES2496765T3 (enExample)
GE (1) GEP20094831B (enExample)
HR (1) HRP20120254T1 (enExample)
HU (1) HUE032040T2 (enExample)
IL (1) IL181474A (enExample)
LT (1) LT2767292T (enExample)
MX (1) MX2007002962A (enExample)
NO (1) NO342596B1 (enExample)
NZ (1) NZ553369A (enExample)
PL (2) PL2415484T3 (enExample)
PT (3) PT1809329E (enExample)
RS (1) RS52198B (enExample)
SI (2) SI2767292T1 (enExample)
WO (1) WO2006033948A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20120225033A1 (en) * 2010-11-24 2012-09-06 Durect Corporation Biodegradable Drug Delivery Composition
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
EP3173072A1 (en) * 2004-10-01 2017-05-31 Ramscor, Inc. Conveniently implantable sustained release drug compositions
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
EP2117521B1 (en) * 2006-11-03 2012-06-27 Durect Corporation Transdermal delivery systems comprising bupivacaine
LT3085363T (lt) * 2007-03-28 2019-06-25 Innocoll Pharmaceuticals Limited Vaistų įvedimo priemonė, skirta vietiniam nuskausminimui, vietinei anestezijai arba nervų blokadai
AU2009212373B2 (en) * 2008-02-08 2013-10-03 Foresee Pharmaceuticals Co., Ltd. Non-polymeric compositions for controlled drug delivery
WO2010077732A2 (en) * 2008-12-09 2010-07-08 Aether Medical Llc Implantable analgesic
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
PL3409271T3 (pl) * 2012-05-16 2024-11-18 Orexa B.V. Środki znieczulające miejscowo dla ułatwienia przyjmowania i retencji pokarmu
CN111956598A (zh) 2013-03-15 2020-11-20 赫伦治疗有限公司 聚原酸酯和质子惰性溶剂的组合物
BR112015029144A2 (pt) * 2013-05-24 2017-07-25 Univ Danmarks Tekniske formulações de gel para guiar radioterapia
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物,以及包括其的组合物和方法
WO2015123734A1 (en) * 2014-02-21 2015-08-27 The University Of Sydney Liquid carrier materials
SI3134068T1 (sl) 2014-04-21 2021-11-30 Heron Therapeutics, Inc. Polimerni dovajalni sistemi z dolgotrajnim delovanjem
WO2018048460A1 (en) 2014-04-21 2018-03-15 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
KR20170025011A (ko) 2015-08-27 2017-03-08 고려대학교 산학협력단 통증완화약물의 지속성 방출을 위한 약학적 조성물 및 그 투여를 위한 투여 장치
EP3452031A4 (en) * 2016-05-05 2019-12-11 Liquidia Technologies, Inc. PRECISION-CONTROLLED LOADING AND RELEASE PARTICLES FOR POST-OPERATIONAL PAIN
BR112018077259A2 (pt) 2016-06-30 2019-06-18 Durect Corporation formulações depot
US10682340B2 (en) 2016-06-30 2020-06-16 Durect Corporation Depot formulations
IL290150B2 (en) * 2016-12-26 2024-03-01 Cellix Bio Private Ltd Compositions and methods for the treatment of chronic pain
WO2018177232A1 (zh) * 2017-03-27 2018-10-04 合肥合源药业有限公司 难溶性复合物或其溶剂合物、药物组合物及其应用
CN111432807A (zh) 2017-10-06 2020-07-17 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库
RU2674025C1 (ru) * 2017-10-25 2018-12-04 Общество с ограниченной ответственностью "Научно-производственная фирма "ЭЛЕСТ" (ООО "НПФ "ЭЛЕСТ") Лекарственное средство на основе порфиринового фотосенсибилизатора копропорфирина для лечения рака кожи методом фотодинамической терапии
CN111655303A (zh) 2018-01-08 2020-09-11 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
WO2019221853A1 (en) 2018-05-12 2019-11-21 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
CN112867484A (zh) 2018-08-28 2021-05-28 铸造疗法股份有限公司 聚合物植入物
US20230052318A1 (en) * 2020-01-06 2023-02-16 Pacira Pharmaceuticals, Inc. Treatment of pain associated with cesarean section surgery with sustained-release liposomal anesthetic compositions
US20230080593A1 (en) 2020-01-10 2023-03-16 Pacira Pharmaceuticals, Inc. Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions
CN115515581A (zh) 2020-01-10 2022-12-23 帕西拉制药股份有限公司 通过给予缓释脂质体麻醉组合物治疗疼痛
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
CA3168712A1 (en) * 2020-02-25 2021-09-02 The University Of North Carolina At Chapel Hill Eutectic based anesthetic compositions and applications thereof
WO2022150708A1 (en) 2021-01-11 2022-07-14 Pacira Pharmaceuticals, Inc. Treatment of hip pain with sustained-release liposomal anesthetic compositions
EP4277702A1 (en) 2021-01-12 2023-11-22 Durect Corporation Sustained release drug delivery systems and related methods
CN115068414B (zh) * 2021-03-16 2023-07-21 湖南慧泽生物医药科技有限公司 供注射用罗哌卡因长效溶液制剂及其制备方法
CN117320696A (zh) 2021-03-19 2023-12-29 帕西拉制药股份有限公司 通过给予缓释脂质体麻醉组合物治疗儿科患者的疼痛
CN115414324A (zh) * 2021-05-31 2022-12-02 中国科学院过程工程研究所 一种载局部麻醉药的乳剂及其制备方法
IL314565A (en) 2022-01-28 2024-09-01 Rebel Medicine Inc Pharmaceutical preparations for pain treatment
US12226610B2 (en) 2022-11-03 2025-02-18 Pacira Pharmaceuticals, Inc. Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US556450A (en) * 1896-03-17 Antifriction-bearing
US2931802A (en) 1958-04-30 1960-04-05 Eastman Kodak Co Mixed esters of glucose and sucrose
GB1088992A (en) 1963-09-19 1967-10-25 Squibb & Sons Inc Protective dressings
US4411890A (en) 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US3743398A (en) * 1971-03-22 1973-07-03 Eastman Kodak Co Motion picture projector
NO139560C (no) 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE7413710L (enExample) 1973-11-01 1975-05-02 Wellcome Found
DE2438352A1 (de) 1974-08-09 1976-02-26 Hoechst Ag Peptidcyclopropylamide mit lh-rh/fshrh-wirkung
DE2438350C3 (de) * 1974-08-09 1979-06-13 Hoechst Ag, 6000 Frankfurt Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
US4360019A (en) 1979-02-28 1982-11-23 Andros Incorporated Implantable infusion device
JPS55154991A (en) * 1979-05-23 1980-12-02 Hisamitsu Pharmaceut Co Inc Beta-d-fructopyranoside derivative
NZ194405A (en) * 1979-08-02 1982-05-25 Dut Pty Ltd Producing liquid hydrocarbon streams by hydrogenation of fossil-based feedstock
US4692147A (en) * 1980-04-02 1987-09-08 Medtronic, Inc. Drug administration device
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4530840A (en) 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
DE3716302C2 (de) 1987-05-15 1996-02-01 Henkel Kgaa Verbesserte resorbierbare Knochenwachse und ihre Verwendung
US4906474A (en) 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
JPS59210024A (ja) 1983-05-13 1984-11-28 Taiyo Kagaku Kk トコフエロ−ル乳化物
US4725442A (en) 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS607418U (ja) 1983-06-28 1985-01-19 株式会社デンソー 歯付スラストワツシヤをもつ軸受装置
US4891225A (en) 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4630019A (en) 1984-09-28 1986-12-16 Westinghouse Electric Corp. Molded case circuit breaker with calibration adjusting means for a bimetal
US4725852A (en) * 1985-05-09 1988-02-16 Burlington Industries, Inc. Random artificially perturbed liquid apparatus and method
US4780320A (en) 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
EP0249347B1 (en) * 1986-06-10 1994-06-29 Euroceltique S.A. Controlled release dihydrocodeine composition
US4970075A (en) 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5234520A (en) 1987-03-20 1993-08-10 Morgan Adhesives Co. Method of making an adhesive construction
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4795641A (en) * 1987-08-20 1989-01-03 Eastman Kodak Company Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US4987893A (en) 1988-10-12 1991-01-29 Rochal Industries, Inc. Conformable bandage and coating material
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
GB8926612D0 (en) 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IT1240643B (it) 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
US5110685A (en) 1990-05-18 1992-05-05 Exxon Chemical Patents, Inc. Low friction, abrasion resistant polymer coating
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
WO1992017900A1 (en) 1991-04-03 1992-10-15 Eastman Kodak Company HIGH DURABILITY MASK FOR DRY ETCHING OF GaAs
JP3313124B2 (ja) * 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
CA2103163C (en) 1991-08-26 1998-10-20 Mou-Ying Fu Lu Compositions and methods for the sublingual or buccal administration of therapeutic agents
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
YU87892A (sh) 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
IL103275A0 (en) 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
DE69230040T2 (de) 1991-10-21 2000-01-05 Peptech Ltd Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5656295A (en) * 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
DE69212497T2 (de) 1991-12-05 1996-12-12 Mallinckrodt Veterinary, Inc., Mundelein, Ill. Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
FI942765A7 (fi) * 1991-12-11 1994-06-10 Procter & Gamble Setyylipyridiniumkloridi ja domifeenibromidi orgaanisessa liottimessa
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5540912A (en) * 1992-03-30 1996-07-30 Alza Corporation Viscous suspensions of controlled-release drug particles
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
DK0659073T3 (da) 1992-09-10 2002-03-11 Childrens Medical Center Bionedbrydelige polymermatrixer med vedvarerende afgivelse af lokalanæstetika
ATE236655T1 (de) 1993-01-06 2003-04-15 Kinerton Ltd Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
KR100321649B1 (ko) * 1993-03-17 2002-07-22 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
DE69405719T2 (de) * 1993-03-17 1998-01-15 Minnesota Mining & Mfg Aerosolzubereitung, enthaltend ein aus einem diol-disäure-derivat abgeleitetes dispergiermittel
DK44193D0 (da) 1993-04-20 1993-04-20 Euromed I S Saarforbinding og klaebemiddel til en saarforbinding eller lignende
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
JP3257750B2 (ja) 1993-07-20 2002-02-18 エチコン・インコーポレーテツド ε−カプロラクトンおよびラクチドの液状コポリマー
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
JPH07112940A (ja) 1993-08-26 1995-05-02 Takeda Chem Ind Ltd 徐放性非経口投与製剤およびその製造方法
AU5895994A (en) 1993-10-04 1995-05-01 Mark Chasin Controlled release microspheres
DE69431071T2 (de) 1993-12-29 2003-03-20 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
CA2187353C (en) * 1994-04-08 2007-05-22 Gerald L. Yewey Liquid delivery compositions
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
HU216291B (hu) 1994-09-23 1999-06-28 Darwin Discovery Limited A levobupivakain és analógjai előállításában alkalmazott racemizálási eljárások
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
JP4118946B2 (ja) * 1994-10-25 2008-07-16 ダーウィン・ディスカバリー・リミテッド レボブピバカインとその類似体の製造法
WO1996012699A1 (en) 1994-10-25 1996-05-02 Chiroscience Limited Crystallisation of levobupivacaine and analogues thereof
GB9501071D0 (en) 1995-01-18 1995-03-08 Chiroscience Ltd Racemisation
US6384227B2 (en) * 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
JP4330175B2 (ja) 1995-06-07 2009-09-16 デュレクト コーポレイション 高粘度液体による制御された送達系
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
HUP9700322A3 (en) * 1995-06-09 2001-03-28 Euro Celtique Sa Formulations and methods for providing prolonged local anesthesia
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
EP1249229A3 (en) * 1996-02-02 2005-02-02 ALZA Corporation Sustained delivery of an active agent using an implantable system
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
CA2260750C (en) * 1996-06-24 2004-11-09 Euro-Celtique, S.A. Methods for providing safe local anesthesia
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
US6046187A (en) * 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US5747051A (en) * 1996-09-27 1998-05-05 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
US6479074B2 (en) 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6572880B2 (en) 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6130200A (en) 1996-12-20 2000-10-10 Alza Corporation Gel composition and methods
US6203813B1 (en) * 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
DE19714765A1 (de) 1997-04-10 1998-10-15 Merck Patent Gmbh Verwendung von niedermolekularen, oligomeren Estern von alpha-Hydroxysäuren und/oder aromatischen o-Hydroxysäuren in kosmetischen Formulierungen
US5919473A (en) * 1997-05-12 1999-07-06 Elkhoury; George F. Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
US5840329A (en) 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US6051558A (en) 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
DE69839355T2 (de) 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
CN1131033C (zh) 1997-11-19 2003-12-17 达尔文发现有限公司 麻醉制剂
RU2180557C2 (ru) * 1998-06-26 2002-03-20 Казахский Государственный национальный университет им. Аль-Фараби Анестезирующий состав пролонгированного действия
SK20012000A3 (sk) 1998-06-29 2001-08-06 Pharmaceuticals Applications Asociates, Llc Transdermálny prostriedok na zmiernenie bolesti
US6312717B1 (en) 1998-07-07 2001-11-06 Bristol-Myers Squibb Company Method for treatment of anxiety and depression
DE19858891A1 (de) 1998-12-19 2000-06-21 Merck Patent Gmbh Verbesserte Knochensiegel
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
AU763945B2 (en) * 1999-06-04 2003-08-07 Skyepharma Inc. Oil-core compositions for the sustained release of hydrophobic drugs
AU5025300A (en) 1999-06-18 2001-01-09 Southern Biosystems, Inc. Compositions for controlled release of the hormone gnrh and its analogs
SK8562002A3 (en) * 1999-12-23 2003-10-07 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations
AU2001237221A1 (en) 2000-01-11 2001-07-24 Roland Bodmeier Implants, particles
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US6992065B2 (en) * 2000-04-19 2006-01-31 Genentech, Inc. Sustained release formulations
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002010436A2 (en) 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Prognostic classification of breast cancer
FR2814308B1 (fr) * 2000-09-15 2003-03-14 France Telecom Procede de gestion de l'usage d'une ligne de telecommunication et systeme de mise en oeuvre
EP2932964A1 (en) * 2000-10-30 2015-10-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
WO2002058670A1 (en) * 2001-01-25 2002-08-01 Euroceltique S.A. Local anesthetic, and method of use
CA2448218C (en) 2001-06-21 2012-05-29 Genentech, Inc. Sustained release formulation
CA2466632C (en) * 2001-11-14 2014-02-11 Alza Corporation Injectable depot compositions and uses thereof
FR2838349B1 (fr) 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
US7736665B2 (en) 2002-05-31 2010-06-15 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4417039B2 (ja) 2002-06-28 2010-02-17 太陽化学株式会社 水中油滴型乳化組成物
JP4712380B2 (ja) 2002-07-26 2011-06-29 三笠製薬株式会社 外用剤
CA2503076A1 (en) 2002-10-25 2004-05-06 Pfizer Products Inc. Novel injectable depot formulations
MXPA05004299A (es) 2002-10-25 2005-08-03 Pfizer Prod Inc Formulacion de liberacion prolongada de agentes activos arilheterociclicos en forma de suspension.
EP2959893A1 (en) * 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CN1726008A (zh) 2002-12-19 2006-01-25 阿尔萨公司 用于从植入装置中传递的稳定的非水单相凝胶及其制剂
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10322469A1 (de) 2003-05-19 2004-12-16 Bayer Healthcare Ag Heterocyclische Verbindungen
US20050106304A1 (en) * 2003-11-14 2005-05-19 Cook Phillip M. Sucrose acetate isobutyrate formulation
US20050171052A1 (en) * 2003-11-14 2005-08-04 Cook Phillip M. Sucrose acetate isobutyrate formulation
US20050232876A1 (en) 2004-04-19 2005-10-20 Robin Lynn Minga Skin care compositions
EP1758095A4 (en) * 2004-05-14 2008-10-01 Yanmar Co Ltd CABIN NOISE SUPPRESSION STRUCTURE
US20050266087A1 (en) 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
EP2361630A1 (en) 2005-02-03 2011-08-31 Intarcia Therapeutics, Inc Implantable drug delivery device comprising particles and an osmotic pump
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP5194273B2 (ja) 2007-09-20 2013-05-08 三菱電機株式会社 半導体装置
SE531980C2 (sv) 2008-01-17 2009-09-22 Avtech Sweden Ab Flygstyrningsförfarande samt datorprogram och datorprogramprodukt för att genomföra förfarandet

Similar Documents

Publication Publication Date Title
JP2008513467A5 (enExample)
JP2012502037A5 (enExample)
JP2006517944A5 (enExample)
BRPI0515372B8 (pt) composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
JP2011137005A5 (enExample)
JP2009523181A5 (enExample)
JP2013507423A5 (enExample)
HRP20171175T1 (hr) Novi triciklički spojevi
HRP20150543T1 (hr) Međuprodukti za pripravu halikondrina b
ME02558B (me) Inhibitori replikacije virusa gripa
EA201071054A1 (ru) Твердый препарат, растворяющийся во рту
JP2009527613A5 (enExample)
JP2011519846A5 (enExample)
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
NI200800318A (es) Composiciones farmacéuticas estabilizadas que comprenden fesoterodina.
JP2014218522A5 (enExample)
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
WO2012001074A3 (en) Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
CO6400138A2 (es) Compuesto anticancerígeno y composición farmacéutica que lo contiene
JP2012517449A5 (enExample)
JP2016511753A5 (enExample)
JP2007238598A5 (enExample)
JP2013513607A5 (enExample)
JP2012522826A5 (enExample)